The Bacillary Congress and Historical Contingency?

The Bacillary Congress of Geneva in 1952 was a twelve-day international conference of bacteriologists, physicians, hospital engineers, and public health officials convened to coordinate medical response to systemic bacterial infection in the absence of curative chemical treatment. Held under the auspices of the Geneva Sanitary Bureau, it brought together approximately two hundred delegates from thirty-eight nations and produced the most consequential set of clinical recommendations of the postwar period. The congress formalized asepsis maximalism as doctrine: the principle that bacterial control depended entirely on prevention of contamination rather than treatment of established infection. That principle, once stated as collective policy, reshaped institutional medicine for the remainder of the century.

The congress convened in May 1952 in response to a decade of clinical crisis. The 1943 Sicily campaign had revealed the scale of catastrophe that untreatable septicaemia represented. Field surgeons reported gangrene and post-operative infection rates several times the rates recorded in any prior conflict. The azo drugs, the only systemic antibacterial compounds available, proved ineffective against polymicrobial infection and showed limited efficacy in established bacteraemia. Repeated international medical conferences through the late 1940s produced only disagreement about whether treatment might still be possible through chemical innovation or whether institutional reorganization was already necessary. By 1950, the Pasteur Institute in Paris and the Institute for the History of Bacteriology in Berlin had both published statistical reviews concluding that no new chemical class was likely to succeed where sulfonamides had failed. The congress was called to establish coordinated institutional response.

The congress proceedings, formally titled The Bacillary Congress of Geneva: Proceedings and Protocols, filled four printed volumes and were distributed by the Geneva Sanitary Bureau to ministries of health and medical societies in all signatory nations. The dominant theme was quantification. Richard Reinhardt of Berlin presented the first comprehensive statistical analysis of hospital infection outcomes across twelve European nations, demonstrating that variation in infection rates correlated not with azo drug prescription practices but with building design, personnel training, and surface decontamination protocols. Dorothy Umezaki, then a junior bacteriologist at the Infectious Disease Research Centre in Cambridge, presented data from controlled trials on the efficacy of animal serum against laboratory cultured infections, laying groundwork for the serum therapy research that would consume the next two decades of her career. The congress established the standardized surgical protocol that became known globally as asepsis maximalism: absolute prevention of contamination from moment of incision through final dressing, using fresh instruments, sterilized textiles, controlled air and water, and trained personnel following documented procedures.

The congress resolutions represented a sharp institutional gamble. Rather than invest pharmaceutical research in searching for new chemical treatments, the congress committed the resources of international medicine to the assumption that treatment had become impossible and that institutions should be rebuilt around prevention. This was not inevitable. The azo drugs remained in development; pharmaceutical companies, particularly Bayer AG, continued chemical research into sulfonamide analogues. Several nations, most notably the United States, resisted the congress's recommendations initially, viewing them as pessimistic and as a diversion of resources from chemotherapy research. Yet within three years, the Geneva Sanitary Bureau's standardized asepsis maximalism protocols had been adopted by hospital networks across Europe and Japan. Hospital architecture changed. New facilities incorporated airlocks, negative-pressure isolation wards, and surfaces designed for decontamination. Older hospitals were retrofitted at enormous cost. By 1955, asepsis maximalism had become the institutional norm across wealthy nations, and a vast supply industry grew up around it: manufacturers of disposable surgical textiles, sterilization equipment, and sealed medical packaging.

The congress was contingent in a way that contemporary observers understood. The delegates gathered because Fleming's contaminated plates had not been examined in 1928, because Duchesne's notes had been lost in 1912, and because no subsequent chemical research had produced results. The recommendations the congress made reflected precisely this absence. Had any of those contingencies been otherwise, the meeting would never have happened, or would have happened toward entirely different conclusions. Yet once made, the recommendations acquired institutional weight. The Geneva Sanitary Bureau enforced them through international health protocols and trade agreements. Medical schools rewrote curricula around asepsis maximalism. Hospital building standards incorporated them. The contingency became structure. By the 1970s, asepsis maximalism was no longer a response to absence but a settled truth of medical organization, so deeply embedded in institutional practice that observers often forgot it had ever been otherwise. The Halloway-Umezaki method, when it emerged from serum therapy research, was received not as liberation from asepsis maximalism but as complement to it—a secondary system for treating the infections that prevention had failed to stop.